Search Results - Mohamed Seid Hedad, Hayget

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor

    Investigation of morpholine isosters for the development of a potent, selective and metabolically stable mTOR kinase inhibitor by De Pascale, Martina, Bissegger, Lukas, Tarantelli, Chiara, Beaufils, Florent, Prescimone, Alessandro, Mohamed Seid Hedad, Hayget, Kayali, Omar, Orbegozo, Clara, Raguž, Luka, Schaefer, Thorsten, Hebeisen, Paul, Bertoni, Francesco, Wymann, Matthias P., Borsari, Chiara

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    EXTH-44. ENHANCING GLIOBLASTOMA CLEARANCE: EMPOWERING ANTI-EGFRVIII CAR T CELLS WITH A PARACRINE SIRPΓ-DERIVED CD47 BLOCKER

    EXTH-44. ENHANCING GLIOBLASTOMA CLEARANCE: EMPOWERING ANTI-EGFRVIII CAR T CELLS WITH A PARACRINE SIRPΓ-DERIVED CD47 BLOCKER by Martins, Tomas, Tatari, Nazanin, Kaymak, Deniz, Bartoszek, Ewelina M, Hogan, Sabrina, Buck, Alicia, Ritz, Marie-Françoise, Wieboldt, Ronja, McDaid, Marta, Gerber, Alexandra, Shekarian, Tala, Hedad, Hayget Mohamed Seid, Schmassmann, Philip, Weiss, Tobias, Laeubli, Heinz, Hutter, Gregor

    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    EXTH-08. IMMUNOTHERAPEUTIC TARGETING OF FIBROBLAST ACTIVATION PROTEIN (FAP) IN TREATMENT REFRACTORY GLIOBLASTOMA USING NOVEL CAR-T CELL THERAPY

    EXTH-08. IMMUNOTHERAPEUTIC TARGETING OF FIBROBLAST ACTIVATION PROTEIN (FAP) IN TREATMENT REFRACTORY GLIOBLASTOMA USING NOVEL CAR-T CELL THERAPY by Tatari, Nazanin, Hedad, Hayget Mohamed Seid, Zingg, Andreas, Bartoszek, Ewelina M, Tschan, Viviane J, Schenker, Timo, Ritz, Marie-Françoise, Miletic, Petar, Venugopal, Chitra, Etter, Manina M, Singh, Sheila K, Läubli, Heinz, Hutter, Gregor

    Get full text
    Article
    Save to List
    Saved in:

Search Tools: